Unique ID issued by UMIN | UMIN000027676 |
---|---|
Receipt number | R000031702 |
Scientific Title | Multicenter study of renal denervation system TCD-16164(feasibility study) |
Date of disclosure of the study information | 2017/06/08 |
Last modified on | 2023/12/12 09:22:58 |
Multicenter study of renal denervation system TCD-16164(feasibility study)
Multicenter study of TCD-16164(feasibility study)
Multicenter study of renal denervation system TCD-16164(feasibility study)
Multicenter study of TCD-16164(feasibility study)
Japan |
Resistant hypertension and uncontrolled hypertension with difficulty of additional antihypertensive medication
Cardiology |
Others
NO
To assess the efficacy and safety of renal denervation system TCD-16164
Safety,Efficacy
Change in mean 24hr SBP at 3 months assessed by ABPM
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Advance the catheter to the target treatment location in the renal artery. Ablate both right and left renal arteries.
20 | years-old | <= |
75 | years-old | >= |
Male and Female
More than 20 and less than 75 years
Patients who are able to understand the informed consent in the study and provide written informed consent to participate to the study
Patients taking three or four antihypertensive drugs of different classes or patients taking two antihypertensive drugs of different classes if it is difficult to treat with additional antihypertensive medications.
Patients who meet all of the following criteria for automated office blood pressure (AOBP)
Systolic BP: 140 mmHg or more
Diastolic BP: 90 mmHg or more
Patients who meet following criteria for mean 24hr BP assessed by ABPM (systolic) with a range between 135 mmHg and 180 mmHg
Female patients agree to use effective form of contraception until 36 months post procedure.
Patients who are considered to be insufficient in terms of improvement in lifestyle and review of antihypertensive therapy.
Patients who have poor adherence to medication.
Patients who have received balloon angioplasty, stenting or renal denervation in the renal artery.
Patients with a solitary kidney.
Patients with eGFR of less than 40 mL/min/1.73 m2.
Patients with a history of cardiac infarction, unstable angina or cerebrovascular disorder within 3 months before the procedure.
Patients with type 1 diabetes mellitus or uncontrolled type 2 diabetes mellitus.
Patients having orthostatic hypotension
Patients with secondary hypertension except for those derived from obstructive sleep apnea syndrome.
Patients who lead a life where day and night are reversed.
Patients with implanted ICD or CRT-D.
Patients having conditions contraindicated to drugs using during intervention
Patients who regularly use nonsteroidal anti-inflammatory drugs.
Patient with renal artery stenosis with the rate of stenosis of 50% or over.
Patients without the renal artery with a diameter between 3 mm and 8 mm.
20
1st name | |
Middle name | |
Last name | Kazuomi Kario |
Jichi Medical University Hospital
Cardiology
Yakushiji 3311-1, Shimotsuke, Tochigi 329-0428, Japan
0285-44-2111
kkario@jichi.ac.jp
1st name | |
Middle name | |
Last name | Keisuke Ozawa |
TERUMO CORPORATION
Clinical Development Department
49F Tokyo Operacitytower, Nishishinjuku, Shinjuku-ku, Tokyo, Japan
03-6742-8244
Keisuke_ozawa@terumo.co.jp
TERUMO CORPORATION
TERUMO CORPORATION
Profit organization
NO
2017 | Year | 06 | Month | 08 | Day |
Unpublished
Completed
2016 | Year | 12 | Month | 20 | Day |
2017 | Year | 04 | Month | 21 | Day |
2017 | Year | 09 | Month | 06 | Day |
2022 | Year | 08 | Month | 27 | Day |
2017 | Year | 06 | Month | 07 | Day |
2023 | Year | 12 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031702